Leerink Partners raises Arcturus Therapeutics target price to $19 from $13
ARCT•Leerink Partners raised its target price for Arcturus Therapeutics to $19 from $13.
Related News
Waldron's expected rise stirs talk inside Goldman of knock-on succession plans
GS•
Trump's moves to boost diesel supplies have not yet lowered prices
USO•
Bradesco adjusts per-share interest after capital increase approval
BBD•
Ero Copper Corp.: Jefferies raises target price to C$56 from C$48
ERO•
Capital One Financial initiates coverage with market perform rating; target price $219
COF•